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Abstract. 
 
Mouse mammary epithelial cells expressing a 
fusion protein of c-Fos and the estrogen receptor 
(FosER) formed highly polarized epithelial cell sheets 
 
in the absence of estradiol. 
 
b
 
-Catenin and p120
 
ctn
 
 were 
exclusively located at the lateral plasma membrane in
a tight complex with the adherens junction protein,
E-cadherin. Upon activation of FosER by estradiol ad-
dition, cells lost epithelial polarity within two days, giv-
ing rise to a uniform distribution of junctional proteins 
along the entire plasma membrane. Most of the 
 
b
 
-cate-
nin and p120
 
ctn
 
 remained in a complex with E-cadherin 
at the membrane, but a minor fraction of uncomplexed 
cytoplasmic 
 
b
 
-catenin increased signiﬁcantly. The epi-
thelial–mesenchymal cell conversion induced by pro-
longed estradiol treatment was accompanied by a com-
plete loss of E-cadherin expression, a 70% reduction in 
 
b
 
-catenin protein level, and a change in the expression 
pattern of p120
 
ctn
 
 isoforms. In these mesenchymal cells, 
 
b
 
-catenin and p120
 
ctn
 
 were localized in the cytoplasm 
 
and in deﬁned intranuclear structures. Furthermore, 
 
b
 
-catenin colocalized with transcription factor LEF-1 
in the nucleus, and coprecipitated with LEF-1–related 
proteins from cell extracts. Accordingly, 
 
b
 
-catenin–
dependent reporter activity was upregulated in mesen-
chymal cells and could be reduced by transient ex-
pression of exogenous E-cadherin. Thus, epithelial
mesenchymal conversion in FosER cells may involve
 
b
 
-catenin signaling.
Key words: cell adhesion • E-cadherin • junctional 
complexes • polarized epithelium • wnt signaling
 
Introduction
 
In monolayers formed by fully polarized epithelial cells,
tight adhesion is mediated by specialized adhesive junc-
tions at their lateral plasma membranes, including actin
filament-associated adherens junctions and intermediate
filament-associated desmosomes. Adherens junctions are
specified by the transmembrane glycoprotein E-cadherin,
whose extracellular domain mediates calcium-dependent,
homophilic cell–cell adhesion between adjacent cells (Sha-
piro et al., 1995; Nagar et al., 1996; Tomschy et al., 1996;
Yap et al., 1997; Adams et al., 1998). The intracellular
domain of E-cadherin associates with a group of proteins,
 
collectively termed catenins (Nathke et al., 1994). 
 
b
 
-cate-
nin and plakoglobin (
 
g
 
-catenin) interact directly with the
cytoplasmic domain of cadherins in a mutually exclusive
way (Hinck et al., 1994; Aberle et al., 1996). They belong
to the armadillo protein family characterized by 13 consec-
utive 42 amino acid repeats in the middle of the polypep-
tide, which are involved in the interaction with E-cadherin
 
(for review see Cowin and Burke, 1996). At their NH
 
2
 
termini, both 
 
b
 
-catenin and plakoglobin bind to the vincu-
lin-related protein, 
 
a
 
-catenin, which, in turn, links the cad-
herin/catenin complex to the actin cytoskeleton, either di-
rectly or via interaction with 
 
a
 
-actinin (reviewed in Cowin
and Burke, 1996) and vinculin (Weiss et al., 1998). A pro-
tein originally identified as a substrate for src tyrosine ki-
nase, p120
 
ctn
 
, was later identified as a member of the cate-
nin protein family (for review see Daniel and Reynolds,
1997) and was found to interact with the cytoplasmic jux-
tamembrane portion of E-cadherin, a region involved in
the regulation of cadherin clustering and cell adhesion
(Ozawa and Kemler, 1998; Yap et al., 1998). Both cad-
herin clustering (Adams et al., 1998; Yap et al., 1997) and
the interaction of the cadherin/catenin complex with the
actin cytoskeleton (Nagafuchi et al., 1994; Aberle et al.,
1996) have been described as crucial for the formation of
stable cell–cell contacts, but the detailed molecular mecha-
nisms are still not completely understood.
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In the past years, it became clear that cadherin-medi-
ated adhesion is a highly dynamic process that is regulated
by several signal transduction pathways (Eger and Fois-
ner, 2000). For instance, activation of various tyrosine ki-
nase-dependent pathways has been described to lead to
phosphorylation of 
 
b
 
-catenin, plakoglobin, and p120
 
ctn
 
,
and to downregulate E-cadherin–based cell adhesion (for
reviews see Barth et al., 1997; Daniel and Reynolds, 1997).
In addition, 
 
b
 
-catenin has been identified as a direct com-
ponent of the wnt/wingless signaling cascade (for recent
reviews see Barth et al., 1997; Ben-Ze’ev and Geiger, 1998;
Willert and Nusse, 1998). This pathway is highly conserved
from flies to mammals and plays a central role in the de-
termination of cell fate decisions during embryonic devel-
opment (Huber et al., 1996a; Moon et al., 1997; Willert
and Nusse, 1998). In the absence of wnt signaling, cytosolic
 
b
 
-catenin was found in a complex with the adenomatous
polyposis coli (APC)
 
1
 
 tumor suppressor protein and axin
(or the related protein conductin; Rubinfeld et al., 1996;
Behrens et al., 1998; Hart et al., 1998; Ikeda et al., 1998;
Itoh et al., 1998) and was described to be constitutively
phosphorylated by GSK3
 
b
 
 on NH
 
2
 
-terminal serine resi-
dues (Yost et al., 1996) that targets the protein for ubiqui-
tination and subsequent proteosomal degradation (Aberle
et al., 1997; Orford et al., 1997). Inhibition of GSK3
 
b
 
 upon
wnt signaling leads to the stabilization and accumulation
of 
 
b
 
-catenin in the cytoplasm and in the nucleus, where it
forms a complex with transcription factors of the T cell
factor/lymphoid enhancer-binding factor-1 (TCF/LEF-1)
family and regulates the expression of various target genes
(Behrens et al., 1996; Huber et al., 1996b; Molenaar et al.,
1996).
Several observations have implicated 
 
b
 
-catenin in car-
cinogenesis. These include the phosphorylation of 
 
b
 
-cate-
nin by oncogenic versions of tyrosine kinases (Barth et
al., 1997; Daniel and Reynolds, 1997), the interaction
of 
 
b
 
-catenin with the tumor suppressor protein APC
(Barth et al., 1997; Daniel and Reynolds, 1997; Gumbiner,
1997) and its identification as a downstream target of the
oncogene Wnt-1. Moreover, mutations in 
 
b
 
-catenin, in-
creased protein levels of 
 
b
 
-catenin, and/or a constitutive
transcriptional activity of 
 
b
 
-catenin/TCF complexes have
been demonstrated in various colon and melanoma cancer
cell lines and in hepatocellular carcinomas (Korinek et al.,
1997; Morin et al., 1997; Rubinfeld et al., 1997; de La Coste
et al., 1998). The oncogene c-myc has been identified as a
potential target gene for 
 
b
 
-catenin/TCF-4 transcriptional
activity in colon cancer cell lines (He et al., 1998). Also,
the
 
 
 
ectopic expression of a stabilized truncated 
 
b
 
-catenin
in keratinocytes of transgenic mice resulted in the devel-
opment of hair tumors (Gat et al., 1998). Cancer progres-
sion has also often been linked to an abnormal down-regu-
lation or even loss of cadherins, leading to an increase in
the invasiveness of primary tumor cells (Perl et al., 1998).
A direct link between 
 
b
 
-catenin’s signaling function and
E-cadherin expression levels in cancer cells, however, has
not been established yet. Putting all available data to-
 
gether, it is likely that the development of cancer in epi-
thelial tissues on the one hand, and epithelial–mesenchy-
mal transition (EMT) during embryogenesis on the other,
both utilize the same basic mechanisms that regulate the
function(s) of cadherins and catenins in cell adhesion and
signaling.
In the present study, we investigated the disintegration
of junctional complexes after loss of epithelial polarity
and EMT, and the diverse functions of 
 
b
 
-catenin in cell
adhesion and signaling. For this purpose, we used a previ-
ously described murine mammary epithelial cell line (IM-
Ep-1-FosER; Reichmann et al., 1992). FosER cells con-
stitutively express a fusion protein consisting of the c-fos
oncogene and the hormone-binding domain of the human
estrogen receptor, whose transactivating function is regu-
lated by the presence of estradiol in the medium. In the
absence of estradiol, FosER is inactive and cells form
highly polarized epithelial cell sheets, whereas addition of
estradiol to the culture medium was shown to induce
FosER activity and to cause loss of epithelial polarity and
EMT characterized by loss of E-cadherin and upregula-
tion of mesenchymal markers (vimentin, proteases, and
protease inhibitors). Here, we show that the majority of
 
b
 
-catenin persisted in a complex with E-cadherin during
loss of epithelial polarity caused by short-term activation
of FosER. However, a small fraction of 
 
b
 
-catenin also ac-
cumulated in an E-cadherin–independent, cytoplasmic
pool. After EMT induced by prolonged FosER activa-
tion, loss of E cadherin was accompanied by translocation
of a significant fraction of cellular 
 
b
 
-catenin to nuclear
sites, frequently colocalizing with LEF-1. Concomitantly,
LEF-1–dependent reporter gene activity was increased in
these mesenchymal cells. Our data provide evidence that
 
b
 
-catenin/LEF-1 signaling is activated upon FosER-
induced EMT.
 
Materials and Methods
 
Cell Culture
 
Mouse mammary epithelial cells constitutively expressing c-Fos estrogen
receptor fusion proteins (FosER, Reichmann et al., 1992) or c-Jun estro-
gen receptor fusion proteins (JunER, Fialka et al., 1996) were cultured on
24-mm Falcon (Becton Dickinson) or 75-mm Transwell (Corning Costar)
permeable filter inserts in high glucose DME, supplemented with 8%
FCS, 10 mM Hepes, pH 7.2, 50 U/ml penicillin, and 50 
 
m
 
g/ml streptomycin
(all Life Technologies) at 37
 
8
 
C in a humidified atmosphere containing 5%
CO
 
2
 
. To activate the FosER fusion protein and induce loss of polarity,
cells were cultured in DME containing 1 
 
m
 
M 
 
b
 
-estradiol (Sigma-Aldrich
Chemie GmbH). Mesenchymal FosER cells were obtained by an initial
treatment of polarized FosER cells with estradiol for 3–4 d, followed by
several passages in the presence of estradiol for 2–3 wk.
 
Metabolic Labeling and 
 
b
 
-Catenin Turnover Analysis
 
Epithelial FosER cells, grown on filters, 4-d estradiol-treated, and mesen-
chymal FosER cells were incubated in methionine-free DME medium
containing 100 
 
m
 
Ci/ml 
 
L
 
-[
 
35
 
S]methionine (New England Nuclear Life Sci-
ence Products, Inc.) for 90 min (pulse), and chased in complete medium
for 1–7 h. 
 
b
 
-Catenin was immunoprecipitated from cell lysates in buffer
containing 1% Triton X-100 and 0.1% SDS (Eger et al., 1997), using mAb
to 
 
b
 
-catenin (see below) and protein G–Sepharose (Sigma Chemical Co.).
Immunoprecipitates were analyzed by SDS-PAGE and autoradiography.
Radioactive label in 
 
b
 
-catenin bands was determined by scintillation
counting and the amount of protein was analyzed by densitometric scan-
ning of Coomassie-stained gel bands.
 
1
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Transient Transfections and Reporter Gene Assays
 
Transient transfection experiments were performed in 60-mm plastic
dishes (Nunc) using lipofectamine (Life Technologies) according to the
manufacturer’s instructions. The following were used: 2 
 
m
 
g luciferase re-
porter plasmids (pTopflash or pFopflash; Korinek et al., 1997) and 2 
 
m
 
g
 
b
 
-galactosidase control reporter plasmid (pAD-CMV1:
 
b
 
gal, kindly pro-
vided by D. Gründler-Thompson, Boehringer-Ingelheim, Vienna, Austria);
1 
 
m
 
g pTopflash/pFopflash, 1 
 
m
 
g pAD-CMV1:
 
b
 
gal, and 5–10 
 
m
 
g E-cadherin
expression vector (pMexE-cadherin) or empty vector (pMexNeo, both pro-
vided by G. Christofori, IMP, Vienna, Austria); 1 
 
m
 
g pTopflash/pFop-
flash, 1 
 
m
 
g pAD-CMV1-
 
b
 
gal, and 5 
 
m
 
g 
 
b
 
-catenin expression vector
(pCS2
 
1
 
mtMMBC6*myc) or empty vector (pCS2
 
1
 
6*myc, both kindly
provided by R. Kemler, Max-Planck Institute of Immunobiology,
Freiburg, Germany; Aberle et al., 1997); 1 
 
m
 
g pTopflash/pFopflash, 1
 
m
 
g pAD-CMV1-
 
b
 
gal, and 5 
 
m
 
g mutated 
 
b
 
-catenin expression vector
(pCS2MMBCS33A6*myc) or empty vector (pCS26*myc, Aberle et al.,
1997); or 1 
 
m
 
g pTopflash/pFopflash, 1 
 
m
 
g pAD-CMV1:
 
b
 
gal and 1 
 
m
 
g he-
magglutinin (HA)-tagged mouse LEF-1 expression vector (Giese and
Grosschedl, 1993) or empty vector. After 48 h, cells were lysed in 200 
 
m
 
l 0.25 M
Tris/HCl, pH 7.5, 0.5% Triton X-100, and soluble fractions were used for
 
b
 
-galactosidase and luciferase assays according to standard protocols.
 
Antibodies
 
The following immunoreagents were used: multiepitope cocktail to des-
moplakin I and II (Progen Biotech.); mAbs to 
 
b
 
-catenin, plakoglobin,
p120
 
ctn
 
, and E-cadherin (Transduction Labs); mAb to ZO-1 (Chemicon
Intl., Inc.); antiserum to 
 
b
 
-catenin and mAb to actin (Sigma Chemical
Co.); antiserum against APC (kindly provided by I.S. Näthke and W.J.
Nelson, Stanford University School of Medicine, Stanford, CA); and affin-
ity-purified antiserum M16C against an NH
 
2
 
-terminal region of mouse
LEF-1 (kindly provided by O. Huber and R. Kemler; Aberle et al., 1997).
Secondary antibodies coupled to peroxidase or alkaline phosphatase were
obtained from Promega or BioRad. Secondary antibodies conjugated to
Bodipy FL were purchased from Molecular Probes, Inc., antibodies cou-
pled to Texas red were from Accurate Chemical and Scientific Corp., or
from Jackson ImmunoResearch Labs, and goat anti–mouse secondary an-
tibodies coupled to 10-nm gold particles and goat anti–rabbit secondary an-
tibodies coupled to 5-nm gold particles were from BioCell Research Lab.
 
Immunofluorescence and Electron Microscopy
 
For immunofluorescence microscopy, FosER cells were fixed on filters in
methanol/acetone (1:1) for 3 min at 
 
2
 
20
 
8
 
C. Alternatively, cells or cryosec-
tions (see below) were fixed with 2.5% paraformaldehyde in PBS for 30
min at 20
 
8
 
C, permeabilized in 0.2% Triton X-100 for 15 min, and incu-
bated in 50 mM NH
 
4
 
Cl/0.01% glycine. After fixation, filters were cut in
small pieces, incubated in 0.2% gelatin or 10% FCS/0.01% glycine for 30
min, and stained with the primary and secondary antibodies for 60 min
each at 20
 
8
 
C. For DNA staining, samples were subsequently treated with
10 
 
m
 
g/ml RNase A (Boehringer Mannheim, Corp.) and stained with 0.1
 
m
 
g/ml propidium iodide (Sigma Chemical Co.). Samples were mounted in
Mowiol and viewed in a Zeiss Axiophot microscope and an MRC 600 con-
focal microscope (BioRad).
For ultrastructural analyses, cells were fixed in 0.5% glutaraldehyde in
0.25 M Hepes buffer, pH 7.4, for 1 h at 20
 
8
 
C and in 1% osmium tetroxide
in PBS for 1 h at 4
 
8
 
C, washed three times in PBS and dehydrated in a
graded series of ethanol (30, 50, 70, and 90% for 15 min each, and 100%
twice for 30 min). Samples were incubated in propylenoxid/Agar 100 (1:1;
Agar Scientific Ltd.), in propylenoxid/Agar 100 (1:2) for 90 min each, and
in Agar 100 for 18 h, with changes of embedding medium after 2 and 16 h.
Subsequently, the epoxy resign was polymerized at 60
 
8
 
C for 3 d. Ultrathin
sections were cut on a Reichert Ultracut S ultramicrotome and stained
with uranyl acetate and lead citrate.
For cryosectioning, cells were fixed with 4% paraformaldehyde in 250 mM
Hepes, pH 7.4, 1.8 mM CaCl
 
2
 
, and 1 mM MgCl
 
2
 
 for 1 h at 20
 
8
 
C, embedded
in 10% gelatine, postfixed in 0.5% glutaraldehyde for 30 min, incubated in
2.3 M sucrose in PBS for 16 h, and frozen in liquid nitrogen. Cryosection-
ing and immunolabeling were done as described in Eger et al. (1997) using
rabbit antiserum to 
 
b
 
-catenin, mAb to p120
 
ctn
 
, and secondary antibodies
coupled to 5- and 10-nm gold particles, respectively. All samples were
viewed in a JEOL JEM-1210 transmission electron microscope at 80 kV.
 
Subcellular Fractionation
 
To obtain total cell lysates, equal amounts of FosER cells in a 10-cm cul-
 
ture dish or on a 75-mm filter insert were lysed in 1 ml hot SDS sample
buffer. For subcellular fractionation in detergent-containing buffers, cells
were lysed in 500 
 
m
 
l ice-cold 50 mM Hepes, pH 7.0, 5 mM MgCl
 
2
 
, 1 mM
EGTA, 100 mM NaCl, 0.1 mM DTT, 0.5% Triton X-100, 0.5 mg/ml
DNase, 0.2 mg/ml RNase (Boehringer Mannheim, Corp.), and protease
inhibitors (1 mM PMSF, 1 mM benzamidine, 10 
 
m
 
g/ml pepstatin, leupep-
tin, and aprotinin) and incubated for 10 min at 20
 
8
 
C. Triton X-100 was
added to a final concentration of 1% and soluble and insoluble fractions
were separated by centrifugation at 20,000 rpm for 20 min at 4
 
8
 
C and dis-
solved in SDS-PAGE sample buffer.
For fractionation in the absence of detergent, FosER cells were scraped
off the filters and incubated in 1 ml hypotonic buffer (5 mM Hepes, pH
7.4, 2 mM MgCl
 
2
 
, and 1 mM EGTA) for 15 min on ice. After adjustment
to isotonic conditions by addition of 10
 
3
 
 buffer A (end concentration,
55 mM Hepes, pH 7.0, 7 mM MgCl
 
2
 
, 2 mM EGTA, 100 mM NaCl, 0.1 mM
DTT, and protease inhibitors), cells were lysed mechanically in a metal
ball cell-cracker (EMBL) and total cell lysates were centrifuged at 30,000 
 
g
 
in a TLA45 rotor (Beckman) for 20 min at 4
 
8
 
C to separate soluble and in-
soluble fractions.
 
Immunoprecipitation
 
For coimmunoprecipitation analyses, 0.5–1 ml of detergent-free or 1%
Triton X-100 containing soluble cell fractions were mixed with 5 
 
m
 
g anti-
bodies or unspecific mouse immunoglobulins as control, and rotated end
over end for 2 h at 4
 
8
 
C. After addition of protein G–Sepharose beads and
a further incubation for 1 h, the beads were collected by centrifugation
and suspended in SDS-PAGE sample buffer.
 
Other Procedures
 
SDS-PAGE was performed according to Laemmli (1970). Electrotransfer
of proteins onto nitrocellulose (0.2 
 
m
 
m; Schleicher & Schueller) was done
in 40 mM glycine, 48 mM Tris, using the BioRad Mini Trans-blot system.
For the immunological detection of the proteins, the Protoblot Immuno-
screening System (Promega) or the Super Signal ECL system (Pierce
Chemical Co.) were used. Quantification of stained protein bands on im-
munoblots was done using the NIH image software and values were nor-
malized for actin levels in the same samples.
For Northern blot analysis, total RNA was prepared from polarized ep-
ithelial cells, 4-d estrogen-treated, and mesenchymal cells (Chomczynski
and Sacchi, 1987), transferred to nylon membranes (Hybond N
 
1
 
; Ny-
comed Amersham, Inc.) and probed for b-catenin mRNA and 28S rRNA
using the AlkPhos direct labeling kit (Nycomed Amersham, Inc.) accord-
ing to the manufacturer’s instructions. The EcoRI–BamHI fragment of
the b-catenin expression vector pCS21mtMMBC6*myc (1,276 bp) was
used as probe for b-catenin, and the oligo 59-CCCGCCGGGCTC-
CCCGGG-39 for 28S rRNA.
Results
Formation of Junctional Complexes in Polarized
FosER Cells
FosER cells formed a tight and well-differentiated epithe-
lial monolayer and developed a high transepithelial electri-
cal resistance (800–1,000 Ohm/cm2) during the cultivation
on porous filter supports in the absence of estradiol for five
to eight days (Reichmann et al., 1992). By immunofluores-
cence and laser scanning confocal microscopy, we investi-
gated the localization of junctional complexes in horizontal
and vertical optical sections through these monolayers.
E-cadherin, the transmembrane protein of the adherens
junctions, and its cytoplasmic interaction partners, b-cate-
nin and p120ctn, were exclusively detected at sites of cell–
cell contacts at the lateral plasma membrane, clearly visible
in vertical optical sections through the epithelial cell mono-
layer (Fig. 1 A, and data not shown). EM confirmed the
formation of a tightly packed epithelial monolayer showing
a close alignment of the lateral plasma membranes of adja-
cent cells with numerous electron-dense cell–cell contactThe Journal of Cell Biology, Volume 148, 2000 176
Figure 1. Immunolocalization of junctional proteins in polarized epithelial cell sheets of FosER cells and redistribution upon estradiol
treatment. Polarized FosER cells grown on filters in the absence of estradiol (A), cells treated with estradiol for 4 d (B), or mesenchy-
mal FosER cells obtained after estradiol treatment for 14 d (C) were processed for immunofluorescence microscopy using antibodies to
junctional proteins as indicated. Confocal images of horizontal (large panels) and vertical (small panels) optical sections through cell
layers are shown. Arrows next to vertical sections indicate position of filter. Bars, 10 mm.Eger et al. b-Catenin Signaling during EMT 177
sites (Fig. 2, A and B, arrowheads). Furthermore, immu-
nogold-labeling of frozen sections of these epithelial cell
sheets revealed that b-catenin and p120ctn were closely as-
sociated with the lateral membrane mostly concentrated in
areas of high electron density, whereas they were absent
within the cytoplasm (Fig. 2 C, arrowheads). In addition,
the localization of the desmosomal protein desmoplakin in
distinct, spot-like structures at more basal regions of the
lateral plasma membrane (Fig. 1 A) indicated the existence
of desmosomes in these cells. Taken together, these data
confirmed and extended earlier findings (Reichmann et al.,
1992) showing that FosER cells formed highly polarized
Figure 2. Ultrastructural
analysis of polarized FosER
cells (A–C) and estradiol-
treated cells (D–F). Un-
treated polarized FosER
cells (A–C), FosER cells
treated with estradiol for 4 d
(D), or mesenchymal cells af-
ter 14-d estradiol treatment
(E and F) were fixed, embed-
ded in epoxy resins, and ul-
trathin sections were ana-
lyzed by transmission EM
(A, B, D, and E); or cells
were frozen in liquid nitro-
gen and cryosections were
processed for immunoelec-
tron microscopy (C and F)
using antibodies to b-catenin
(filled arrowheads) and
p120ctn  (open arrowheads).
C, Cytoplasm; Ex, extracellu-
lar space. Bars: (A, D, and
E) 10 mm; (B) 500 nm; (C
and F) 100 nm.The Journal of Cell Biology, Volume 148, 2000 178
epithelial cell sheets in the absence of estradiol and indi-
cated that b-catenin and p120ctn were predominantly in-
volved in cell–cell adhesion at the lateral plasma mem-
brane in these cells.
Rearrangements of Junctional Proteins upon Loss of 
Epithelial Polarity and EMT
Next, we studied the fate of junctional complexes and the
reorganization of junctional proteins upon addition of es-
tradiol to the culture medium. Within two to four days,
cell–cell interactions were significantly reduced, as re-
vealed by EM. Large intercellular gaps formed between
membranes of adjacent cells and only a few remnants of
cell–cell contact sites were detectable (Fig. 2 D). In addi-
tion, cells started to grow in multilayers and the most basal
cells in these multilayers dramatically changed their mor-
phology from a cobblestone-like to an extremely elon-
gated spindle-like cell shape (Fig. 1 B).
Confocal immunofluorescence microscopy revealed the
disintegration of adherens junctions and desmosomes in
the majority of the cells after two to four days of estradiol
treatment. In these cells, E-cadherin showed a nonpolar
distribution over the entire cell surface (Fig. 1 B). Con-
comitantly, the localization of the catenins was also mark-
edly altered. A large fraction of b-catenin (Fig. 1 B) and
p120ctn  (data not shown) colocalized with E-cadherin
along the entire surface of the plasma membrane, but a
second pool of these catenins was found diffusely distrib-
uted throughout the cytoplasm and appeared to be inde-
pendent of E-cadherin. In addition, desmoplakin disap-
peared from the plasma membrane and was detected in
intracellular distinct dot-like structures (Fig. 1 B), indicat-
ing that desmosomal structures were internalized as large
complexes upon loss of epithelial polarity.
Mesenchymal cells, obtained by prolonged treatment
with estradiol for two weeks or by cultivation after a 48-h
pulse of estradiol (Reichmann et al., 1992), exhibited a
highly elongated and spindle-shaped phenotype detect-
able in confocal horizontal sections (Fig. 1 C) and failed to
form extensive cell–cell contacts, as seen more clearly in
electron micrographs (Fig. 2 E). Immunofluorescence-
staining revealed a uniform cytoplasmic distribution of
b-catenin (Fig. 1 C) and p120ctn (not shown), as well as in-
tranuclear  b-catenin structures. Immunogold EM con-
firmed that b-catenin and p120ctn were barely detectable at
the plasma membrane of mesenchymal cells, but were
scattered throughout the cytoplasm (Fig. 2 F, arrowheads)
and within the nucleus (see also Fig. 5). In contrast, other
junctional proteins, like E-cadherin (Fig. 1 C) and des-
moplakin (data not shown) were not detectable above
background levels in the mesenchymal FosER cells. Thus,
b-catenin and p120ctn were apparently expressed at signifi-
cant levels in the mesenchymal cells obtained after EMT,
but they were mainly found in the cytoplasm and the nu-
cleus, as described previously for b-catenin in a variety of
mesenchymal cells (Kim et al., 1998).
Changes in the Expression Levels of Junctional 
Proteins after EMT 
To gain insight in the regulation of junctional proteins af-
ter FosER activation, we investigated the expression levels
of these proteins at various stages of epithelial depolariza-
tion and after FosER-induced EMT. Total cell lysates ad-
justed to the same total protein content were analyzed by
immunoblotting. Strikingly, the overall amounts of junc-
tional proteins did not significantly change during the first
four days of estradiol treatment, except for a slight, tran-
sient upregulation of desmoplakin I 1 II (Fig. 3 A). In the
mesenchymal cells obtained after EMT, the expression
profile of junctional proteins was markedly altered. In ac-
cordance with the immunofluorescence studies, the ex-
pression of the epithelial-specific proteins, E-cadherin and
desmoplakin I 1II, was almost completely downregulated
(Fig. 3 A, mes). In contrast, the mesenchymal cells re-
tained 10–30% of the b-catenin level present in the epi-
Figure 3. Protein expression levels of junctional proteins (A),
and  b-catenin mRNA levels (B) and b-catenin turnover rates (C)
during various stages of estradiol treatment. A, Equivalent
amounts of total cell lysates of untreated polarized FosER cells
(E2), cells treated with estradiol for 2 d (E2d) and 4 d (E4d), and
mesenchymal FosER cells after 14-d estradiol treatment (mes)
were analyzed by immunoblotting using antibodies to indicated
proteins. B, Northern blot analysis of total RNA from these cells
probed with b-catenin cDNA fragment and with 28S rRNA oligo
as a control for equal loading. C, Cells were metabolically labeled
with [35S]methionine and chased in unlabeled medium for 1–7 h.
b-Catenin was immunoprecipitated from cell lysates and analyzed
by SDS-PAGE and autoradiography. The specific b-catenin label
was determined by counting radioactivity in the b-catenin band
in a scintillation counter. Values were normalized for protein
content, determined by densitometric scanning of Coomassie
stained gel bands, and plotted against the chase time in a semilog-
arithmic graph. Best linear curve fits were made from values be-
tween 2- and 7-h chase time (one particular experiment is
shown), and half-lives (T1/2) were calculated from triplicate anal-
yses (bar graph). Mean values and SD were: E2, 5.64 h, SD 5
0.56; E4d, 7.35 h, SD 5 0.84; and mes, 2.37 h, SD 5 0.38.Eger et al. b-Catenin Signaling during EMT 179
thelial FosER cells before estradiol treatment. Control
blots of the same lysates with antibodies against actin con-
firmed equal loading. Interestingly, we observed a dra-
matic change in the expression pattern of p120ctn proteins.
In the epithelial FosER cells, p120ctn was detected as a
closely spaced double-band of z100 kD and a weaker
double-band at z120 kD (Fig. 3 A). The z100-kD pro-
teins were strongly downregulated in the mesenchymal
cells, whereas the z120-kD proteins persisted and became
the predominant p120ctn forms after EMT. It is likely that
these different forms of p120ctn represent isoforms of the
protein derived by the usage of alternative start codons
and by alternative splicing of COOH-terminal exons. Al-
though the specific isoforms expressed in epithelial and
mesenchymal FosER cells remain to be identified, our
findings correlate with the previously observed predomi-
nant expression of 100- and 120-kD p120ctn isoforms in ep-
ithelial and in highly motile fibroblastoid cells, respec-
tively (Reynolds and Daniel, 1997).
To test whether the decrease in b-catenin level, which
we observed upon FosER-induced EMT, resulted from
changes in the expression of the b-catenin gene, as previ-
ously reported for E-cadherin (Reichmann et al., 1992), or
from a change in the turnover rate of the protein, we
performed Northern blot analysis and pulse–chase meta-
bolic labeling experiments. Northern blot analysis using
total RNA of epithelial FosER cells, of four-day estra-
diol-treated, and of mesenchymal cells revealed that the
amount of b-catenin mRNA was similar in all cell types
(Fig. 3 B). In the pulse–chase experiments, epithelial, four-
day estradiol-treated, and mesenchymal FosER cells were
pulse-labeled for 90 min using [35S]methionine and chased
in unlabeled medium for up to seven hours. From the de-
crease in the specific b-catenin label, we calculated a half-
life of five to six hours for b-catenin in epithelial cells (Fig.
3 C). Whereas the b-catenin half-life was slightly increased
to six to eight hours upon four-day estradiol treatment, it
significantly dropped to values below 2.6 h in mesenchymal
FosER cells. Thus, it is very likely that an increased turn-
over rate of b-catenin in mesenchymal cells versus epithe-
lial cells, which is likely caused by the downregulation of
E-cadherin, leads to a reduction in total b-catenin protein
level. Nevertheless, the half-life of b-catenin in mesenchy-
mal cells was still significantly higher than those reported
for the protein in various E-cadherin–deficient cell lines
(below 40 min; see Papkoff, 1997; Rubinfeld et al., 1997),
and is close to values observed upon stabilization of b-cate-
nin by wnt (Papkoff et al., 1996) and by proteosomal pro-
tease inhibitors (Aberle et al., 1997), or close to the half-
life of stabilized mutated b-catenin in melanoma cells
(Rubinfeld et al., 1997). These data indicated that, com-
pared with other E-cadherin–lacking cells, in mesenchymal
FosER cells, b-catenin seems to be stabilized to a certain
extent also by an E-cadherin–independent mechanism.
Complex Stability and Interactions of Junctional 
Proteins upon Epithelial Depolarization and EMT 
Our data showed significantly reduced cell–cell adhe-
sion at the initial stages of estradiol-treatment, which
was completely lost after prolonged treatment. The loss
of cell adhesion is usually correlated with a disintegra-
tion of all adhesive junctions at the lateral membrane.
Therefore, we wanted to investigate if and how the in-
teractions between junctional proteins were changed
during this process. To specifically analyze the potential
dissociation of b-catenin from the E-cadherin complex,
we performed subcellular fractionation of cell lysates
made in the absence of Triton X-100. As expected, the
membrane-anchored E-cadherin was exclusively found
in the pellet fraction upon centrifugation of the lysate at
30,000 g (Fig. 4 A). Although the majority of b-catenin
was also found in the pellet fraction of epithelial and
four-day estradiol-treated cells, a minute amount of sol-
uble b-catenin found in polarized cells was strongly in-
creased upon estradiol-treatment of the cells for four
days (Fig. 4 A). This increase of cytoplasmic-free
b-catenin was even more evident after immunoprecipi-
tating the protein from the detergent-free supernatant
fractions (Fig. 4 B, 2TX 100). Immunoblot analysis of
the immunoprecipitates using an antibody to E-cadherin
confirmed the absence of detectable amounts of E-cadherin.
Thus, an E-cadherin–independent pool of b-catenin
clearly increased during FosER-induced depolarization
of the cells. To test whether this E-cadherin–indepen-
dent pool of b-catenin interacted with APC, as previ-
ously reported for various colon carcinoma cell lines
(Barth et al., 1997), we probed the b-catenin immuno-
precipitates with antiserum to APC. Although APC was
clearly present in polarized, as well as unpolarized and
mesenchymal FosER cells (Fig. 3 A), we did not ob-
serve a significant coprecipitation of APC with b-cate-
nin at either stage.
Interestingly, in the detergent-free lysates of mesen-
chymal cells, the majority of b-catenin persisted in the
insoluble fraction (Fig. 4 A, mes). As these cells lack
E-cadherin, which could recruit b-catenin to the insolu-
ble membrane fraction, other cytoskeletal associations
and/or the nuclear translocation of b-catenin might be
responsible for its insolubility in the mesenchymal
cells.
To analyze potential changes in the stoichiometry of
b-catenin and E-cadherin in b-catenin complexes after
FosER-induced epithelial depolarization and EMT, we
lysed the cells in buffers containing 1% Triton X-100,
which solubilized a significant fraction of adherens junc-
tion proteins (data not shown). Immunoprecipitates
obtained with b-catenin antibodies contained similar
amounts of b-catenin and E-cadherin in both polarized
and unpolarized cells (Fig. 4 B, 1 TX-100). None of these
proteins were brought down in control immunoprecipi-
tates with irrelevant antibodies (data not shown). As
there were no significant changes in the stoichiometry of
the proteins in the precipitated complexes within 4-d es-
tradiol treatment, we concluded that the major pool of
b-catenin remained associated with E-cadherin in the
FosER cells after initial loss of epithelial polarity. The
mesenchymal cells after EMT completely lacked E-cad-
herin, and concomitantly, b-catenin immunoprecipitates
did not contain any E-cadherin. Interestingly, these im-
munoprecipitates did not contain significant amounts of
APC (Fig. 4 B), suggesting that the majority of b-catenin
in mesenchymal cells existed in APC-independent struc-
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Nuclear Translocation of b-Catenin and p120ctn in 
Mesenchymal FosER Cells
To further analyze the subcellular distribution of b-cate-
nin in the absence of endogenous E-cadherin, we studied
the mesenchymal cells after EMT by confocal laser scan-
ning microscopy. Confocal images of horizontal optical
sections through mesenchymal cells revealed a mostly dif-
fuse staining of b-catenin in the cytoplasm (Fig. 1 C). In the
majority of cells, however, b-catenin was also detected in
intranuclear structures (Fig. 1 C). At higher magnification,
brightly stained, discrete spot-like b-catenin structures
were visible throughout the nucleus (Fig. 5 A, whole-
mount). Costaining of nuclei with the DNA stain propid-
ium iodide confirmed that the optical sections were put
through the middle of the nucleus and that the b-catenin
structures were indeed intranuclear. As the nuclear stain-
ing of b-catenin might be underrepresented due to a re-
stricted accessibility of the antibodies to the b-catenin pro-
tein within the bulky chromatin structure in whole-mount
preparations, we also performed cryosectioning of frozen
cells. Immunofluorescence microscopy of these sections
strongly labeled dot-like b-catenin structures in the nu-
clear compartment (Fig. 5 A, cryosection). In addition, we
performed immunoelectron microscopy of frozen sections
to confirm our immunofluorescence data on the ultra-
structural level and to perform semiquantitative statistical
analysis. In these sections, nuclei were clearly discernable
due to the electron-dense chromatin structures and the bi-
layered nuclear envelope (Fig. 5 B). At higher magnifica-
tion, b-catenin–specific immunogold label was clearly de-
tectable in clusters both within the nucleus (Fig. 5 B, N)
and in the cytoplasm (Fig. 5 B, C) of mesenchymal cells
(Fig. 5 B, arrowheads). A crude quantification of the in-
tranuclear versus cytoplasmic distribution of b-catenin
was obtained by counting the number of gold particles in
the nucleus and in the surrounding cytoplasm in com-
parable areas on the sections. According to this quantifica-
tion, there was a significant translocation and accumula-
tion of b-catenin in the nucleus upon FosER-induced
EMT (Fig. 5 C).
Interestingly, immunoelectron microscopy demonstrated
that p120ctn protein was also detectable in nuclei of mesen-
chymal FosER cells, although to a lesser extent than
b-catenin (Fig. 5 C). These data show for the first time
that p120ctn resembles b-catenin in its ability to translocate
to the nucleus. Interestingly, p120ctn has recently been
demonstrated by yeast two-hybrid and coimmunopre-
cipitation studies to interact with Kaiso, a member of the
POZ-ZF transcription factor family, which was localized
in intranuclear dot-like structures (Daniel and Reynolds,
1999).
Interaction of b-Catenin with a LEF-1–related Protein 
in Mesenchymal FosER Cells 
The nuclear localization of b-catenin in mesenchymal
FosER cells prompted us to test for interactions of b-cate-
nin with LEF-1/TCF transcription factors. Immunoblot
analysis of total cell lysates, using an affinity-purified LEF-1
antibody (Huber et al., 1996b), revealed a major band at
z50 kD and several minor bands, suggesting that LEF-1
and potential LEF-1/TCF isoforms are expressed in mes-
enchymal FosER cells (Fig. 6 A, cell lysate). Furthermore,
the antibody detected brightly stained spot-like structures
scattered throughout the nucleus in both polarized and
mesenchymal FosER cells (Fig. 6 B). Double immunofluo-
rescence microscopy using antibodies to b-catenin and
LEF-1 showed that the LEF-1–specific staining colocal-
ized frequently with that of nuclear b-catenin in mesen-
chymal cells, whereas in polarized cells, b-catenin was re-
stricted to the plasma membrane and did not overlap with
the nuclear LEF-1 structures (Fig. 6 B). Thus, unlike po-
larized cells, in mesenchymal cells LEF-1 and b-catenin
may form complexes within the nucleus. To investigate on
the biochemical level whether b-catenin interacted with
LEF-1–related proteins, we lysed mesenchymal FosER
cells in buffers containing Triton X-100 and DNase and
performed coimmunoprecipitation analysis from the solu-
ble fraction using b-catenin antibodies. Both b-catenin
and the LEF-1–related protein of z50 kD were detected
in the immunoprecipitate by immunoblotting, whereas
they were absent in control precipitates using an unrelated
mouse antibody (Fig. 6 A).
Figure 4. Analysis of the
E-cadherin–independent pool
of b-catenin and of b-catenin
complexes in polarized and
estradiol-treated FosER cells.
A, Untreated FosER cells
(E2), and cells treated with
estradiol for 2 d (E2d), and
4 d (E4d), and mesenchymal
FosER cells after 14-d estra-
diol treatment (mes) were
lysed in detergent-free buffer
and soluble (S) and insoluble
(P) cell fractions were ob-
tained by centrifugation of to-
tal cell lysates at 30,000 g for
20 min. B, Cells were lysed in
buffers without (2TX-100) or with (1TX-100) Triton X-100 and b-catenin was immunoprecipitated from the soluble cell fractions. Im-
munoblots of cell fractions and of b-catenin immunoprecipitates using antibodies to indicated proteins are shown.Eger et al. b-Catenin Signaling during EMT 181
Activation of FosER
Augments b-Catenin/LEF-1–dependent
Transcriptional Activation
To test the functional significance of the nuclear transloca-
tion of b-catenin and its association with nuclear LEF-1
upon EMT, we performed a reporter gene assay using
the pTopflash/pFopflash reporter constructs, previously
shown to specifically reveal LEF-1/TCF/b-catenin–depen-
dent transcriptional activity (Korinek et al., 1997). Polar-
ized FosER cells, four-day estradiol-treated, and mesen-
Figure 5. Nuclear localiza-
tion of b-catenin and p120ctn
after EMT. A, Mesenchymal
FosER cells after 14-d es-
tradiol treatment (whole-
mount) or cryosections ob-
tained from these cells were
processed for immunofluo-
rescence microscopy using
antibodies to b-catenin and
the DNA stain propidium io-
dide. Double fluorescence
confocal images are shown.
Bar, 10 mm. B, Cryosections
of mesenchymal FosER cells
were processed for immuno-
electron microscopy using
antibodies to b-catenin. Low
magnifications (left) and
higher magnifications (right)
of indicated areas are shown.
Arrowheads denote gold la-
bel. C, cytoplasm, N, nucleus.
Bars: (left) 500 nm; (right)
100 nm. C, Semiquantitative
analyses of the relative
amount of b-catenin- and
p120ctn-specific label in the
nucleus versus cytoplasm in
polarized epithelial (E2)
and mesenchymal (mes)
FosER cells. The number of
gold particles was counted in
equivalent areas of the cyto-
plasm and the nucleus and
the percentage of nuclear
particles was calculated.
Data represent statistical
mean values of 50 counted
samples. Mean values and
SD were: b-catenin, E2
(10%, SD 5 10), mes (70%,
SD 5 20); and p120ctn, E2
(5% SD 5 4), mes (30%
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chymal cells were transiently transfected with the reporter
plasmid, together with a CMV promoter-driven b-galac-
tosidase reporter construct to normalize for transfection
efficiency. Normalized luciferase reporter activity was al-
ready slightly elevated in unpolarized FosER cells and was
further increased in mesenchymal cells up to a maximum,
tenfold higher than the basal activity seen in control epi-
thelial cells (Fig. 6 C, filled bars). Using the pFopflash re-
porter construct containing a mutant version of the LEF/
TCF binding sites, we also observed a slight increase of the
luciferase activity upon four-day estradiol treatment, but
the activity was not further upregulated in mesenchymal
cells (open bars). As the specific stimulation of LEF-1/
TCF transcriptional activity seen with the pTopflash re-
porter construct strictly depends on the formation of a
complex of LEF/TCF factors with b-catenin (Korinek et al.,
1997; Hsu et al., 1998), we concluded that b-catenin
formed a transcriptionally active complex with LEF-1/
TCF-related proteins in the nucleus of mesenchymal cells.
To address the question whether induction of LEF-1/
TCF transcriptional activity is specific for EMT or just a
consequence of increased AP-1 activity, the same assay
was performed with the related mammary cell line JunER,
which stably expresses a c-JunER fusion protein. JunER
cells showed a dramatic loss of epithelial polarity upon in-
cubation with estradiol, but completely failed to undergo
Figure 6. Formation of a tran-
scriptionally active b-catenin/
LEF-1 complex in mesenchy-
mal FosER cells after 14-d es-
trogen treatment. A, Mesen-
chymal FosER cells were
lysed in buffer containing Tri-
ton X-100 and DNase, and
b-catenin was immunoprecip-
itated from the soluble cell
fraction. Control immunopre-
cipitates were obtained with
an unrelated mouse IgG. Im-
munoblots of the total cell ly-
sate using affinity-purified an-
tiserum to LEF-1 and relevant
areas of immunoblots of the
b-catenin (IP-b-catenin) and
control (IP-control) immuno-
precipitates using antibodies
to b-catenin and LEF-1 are
shown. B, Polarized or mesen-
chymal FosER cells were
treated for immunofluores-
cence microscopy using an
mAb to b-catenin and an
affinity-purified antibody to
LEF-1. Confocal double im-
munofluorescence images are
shown. Bar, 10 mm. C, Polar-
ized epithelial (E2), 4-d estra-
diol-treated (E4d) and mesen-
chymal (mes) FosER cells
after 14-d estradiol treatment,
or polarized (E2) and 14-d
estradiol-treated JunER cells
were transiently transfected
with TOPFLASH luciferase
reporter plasmid containing
multimerized LEF-1/TCF
binding sites (filled bars) or
mutated FOPFLASH plas-
mid (open bars). The level of
luciferase activity was normal-
ized for the expression of a
cotransfected CMV–b-galac-
tosidase expression plasmid.
Fold activation was quantitated relative to the level of luciferase activity from polarized FosER and JunER cells, respectively. All ex-
periments were performed three to five times. Mean values and SD were: FosER cells/TOPFLASH, E2 (1.0); E4d (3.28, SD 5 0.87);
mes (7.23, SD 5 3.36); FosER cells/FOPFLASH, E2 (0.7, SD 5 0.15); E4d (2.5, SD 5 0.20); mes (2.7, SD 5 0.20); JunER cells/TOP-
FLASH cells, E2 (1.0); E14d (1.23, SD 5 0.18); and JunER cells/FOPFLASH, E2 (0.60, SD 5 0.2); E14d (0.73, SD 5 0.13).Eger et al. b-Catenin Signaling during EMT 183
EMT even after prolonged estradiol treatment (Fialka et al.,
1996). Upon transfection of the reporter constructs into
JunER cells, no significant increase of luciferase reporter
activity relative to the basal activity in polarized cells was
detected upon estradiol activation of the JunER cells for
up to 14 d (Fig. 6 C). JunER cells do not lose E-cadherin,
but show a similar upregulation of AP-1 target genes (Fi-
alka et al., 1996) as Fos-ER cells. Therefore, we conclude
that the increase of LEF-1/TCF-dependent transcriptional
activity detected in FosER cells upon estradiol treatment
was not solely caused by estrogen-induced AP-1 activa-
tion.
To provide additional support for the idea that E-cad-
herin–independent b-catenin is directly responsible for
the increase of LEF-1/TCF transcriptional activity upon
FosER-induced EMT, we transiently transfected an
E-cadherin expression construct into epithelial or mesen-
chymal FosER cells, together with the LEF-1/TCF re-
porter plasmids. Ectopically expressed E-cadherin in
E-cadherin–negative embryonic stem cells and in SW480,
NIH3T3, and 293-T cells (Orsulic et al., 1999), or even
transfected cytoplasmic domains of N- or E-cadherin and
derivatives thereof containing the b-catenin binding site
(Sadot et al., 1998), recently have been shown to compete
with endogenous LEF-1/TCF proteins for binding to
b-catenin and, hence, reduced the transcriptional activa-
tion of the reporter gene. Cotransfection of the E-cadherin
expression vector in two- to tenfold excess over the LEF-1/
TCF reporter construct into mesenchymal FosER cells
caused a progressive reduction of reporter luciferase activ-
ity (12% decrease at twofold excess to 30–50% reduction
at a tenfold excess; Fig. 7, filled bars). Expression of exog-
enous E-cadherin in mesenchymal cells was confirmed by
immunoblotting, revealing a significant increase of the
E-cadherin signal in the transfected cells (Fig. 7). In epi-
thelial FosER cells, the same amounts of exogenous
E-cadherin had less pronounced effects on the already
low, basal level of transcriptional activity (Fig. 7, open
bars).
If the reexpression of E-cadherin caused a reduction of
LEF-1/TCF-dependent transcriptional activity by recruit-
ing soluble b-catenin to the plasma membrane, exogenous
Figure 7. Dependence of b-catenin/LEF-1 transcriptional activ-
ity on ectopic expression of E-cadherin, wild-type and mutated
b-catenin, and LEF-1. Mesenchymal (filled bars) and polarized
epithelial (open bars) FosER cells were transiently transfected
with TOPFLASH luciferase reporter plasmid, together with in-
creasing amounts of expression plasmids (2–10 mg) encoding
E-cadherin or expression plasmids encoding myc-tagged b-cate-
nin, stable, mutated b-catenin*, or expression plasmids encoding
HA-tagged LEF-1 alone or in combination with mutated b-cate-
nin (b-cat*). The level of luciferase activity was normalized for
the expression of a cotransfected CMV–b-galactosidase expres-
sion plasmid. Luciferase activities relative to controls obtained by
cotransfections with empty expression vectors are shown. Exper-
iments were repeated at least twice for each E-cadherin expres-
sion study and at least three times for all others. Means and SD
were: for E-cad/mes, 2 mg (0.88, SD 5 0.02); 5 mg (0.72, SD 5
0.01); 10 mg (0.60, SD 5 0.13); for Ecad/pol, 2 mg (0.14, SD 5
0.01); 5 mg (0.13, SD 5 0.01); 10 mg (0.08, SD 5 0.03); for bcat/
mes (1.35, SD 5 0.25); bcat*/mes (2.05, SD 5 0.35); bcat/pol
(0.11, SD 5 0.02); bcat* (0.16, SD 5 0.02); for LEF-1 (7.85, SD 5
0.35); and LEF1bcat* (16.35, SD 5 0.35). Experiments were also
performed once with mutated FOPFLASH plasmid, showing no
significant effect upon ectopic protein expression. The expression
of ectopic proteins is shown by immunoblot analyses of total cell
lysates of transfected mesenchymal cells using antibodies to
E-cadherin, b-catenin, and the HA tag.The Journal of Cell Biology, Volume 148, 2000 184
expression of b-catenin should enhance transcriptional ac-
tivation by LEF-1/TCF. Indeed, cotransfection of reporter
constructs with expression plasmids for myc-tagged, wild-
type b-catenin, or NH2 terminally mutated, nondegrad-
able b-catenin (Aberle et al., 1997) further increased the
high luciferase activity in mesenchymal cells (Fig. 7, filled
bars). While transfection of full-length b-catenin further
enhanced the already elevated reporter gene expression in
mesenchymal cells z1.4-fold over mock transfected sam-
ples, mutated stable b-catenin augmented luciferase activ-
ity more than twofold. Ectopic expression of myc-tagged
b-catenin was verified by immunoblotting (Fig. 7). The ex-
pression of b-catenin in polarized FosER cells had only
minor effects on the reporter gene activity (Fig. 7, open
bars). Taken together, the transfection studies point to an
elevated b-catenin/LEF-1 transcriptional activity in mes-
enchymal versus polarized cells, which is apparently de-
pendent on the amount of soluble, E-cadherin–indepen-
dent b-catenin.
To test whether the high b-catenin–dependent tran-
scriptional activity in mesenchymal cells is also dependent
on the amount of LEF-1 present in the cells, we cotrans-
fected a mouse LEF-1 expression plasmid together with
the reporter construct into the cells. Transcriptional activ-
ity in cells expressing HA-tagged exogenous LEF-1 (Fig.
7, see immunoblot) was eightfold higher than the activity
in mock transfected cells, and could be further elevated
twofold upon coexpression of mutated exogenous stable
b-catenin (16-fold over mock transfected cells; Fig. 7).
Our results clearly demonstrated that endogenous b-cat-
enin and endogenous LEF-1/TCF proteins in mesen-
chymal FosER cells were able to form a transcriptionally
active complex, which could be increased further upon ec-
topic expression of b-catenin and LEF-1 without addi-
tional signals.
Discussion
EMT, the conversion of epithelial cells into a fibroblas-
toid, mesenchymal phenotype occurs both during early
embryonic development and during progression of cancer
to metastatic stages (Oft et al., 1996, 1998). EMT seems to
involve a complex series of overlapping signaling path-
ways and molecular mechanisms, whose interdependence
is still poorly understood. The previously established
FosER cell line represents an ideal and unique cell culture
model system to study the regulation of the emerging dual
role of E-cadherin and catenins in cell adhesion and sig-
naling at various stages of epithelial depolarization and af-
ter EMT, since depolarization and EMT can be condition-
ally induced by estradiol-dependent induction of FosER
protein function. Our studies revealed that depolarization
and EMT involved clearly discernable steps, which may in-
clude different molecular mechanisms. Initially, cells lost
epithelial polarity, as indicated by a redistribution of
E-cadherin–containing complexes over the entire plasma
membrane. In a second process, a small cytoplasmic pool
of b-catenin accumulated, which did not interact with
E-cadherin. This b-catenin pool apparently also failed to
associate with the b-catenin downregulating APC com-
plex. The third important, but clearly delayed, event in
FosER-induced EMT was the complete loss of E-cadherin
protein, which has been shown to be correlated with the
upregulation of vimentin and other mesenchymal markers
(Reichmann et al., 1992). The complete loss of E-cadherin
in the mesenchymal state is likely to further increase the
free pool of b-catenin and to make it increasingly available
for signaling processes. The fourth mechanism involved
the accumulation of b-catenin in the nucleus, its interac-
tion with LEF-1–related proteins, and the activation of
LEF-1/b-catenin–dependent transcriptional activity. Com-
pared with previously published experiments on the cell
adhesion and signaling activities of b-catenin in mamma-
lian cell systems, our observations provide novel insights
into these processes for the following reasons. First, most
previous studies on cell adhesion and/or signaling func-
tions of b-catenin in mammalian cells used either trans-
formed cell lines, which expressed abnormally high levels
of b-catenin (Korinek et al., 1997; Rubinfeld et al., 1997;
Hart et al., 1998), or highly overexpressed b-catenin or
b-catenin–binding proteins in a normal b-catenin back-
ground (Behrens et al., 1996, 1998; Huber et al., 1996b;
Ikeda et al., 1998; Simcha et al., 1998). In contrast to these
studies, we present evidence for the involvement of endog-
enous b-catenin expressed at physiological levels in both
cell adhesion and signaling. Therefore, potential artifacts
produced by the high unphysiological level of these pro-
teins can be mostly excluded in our studies. Second, we
show and compare endogenous b-catenin activities in a
single cell line at various cellular phenotypes, i.e., in the
polarized stage, upon depolarization, and upon EMT.
Interactions of b-Catenin with E-Cadherin Are 
Predominant and May Regulate b-Catenin Functions
Our experiments showed that E-cadherin is the predomi-
nant interaction partner of endogenous b-catenin. Al-
though the disintegration of junctional complexes and the
redistribution of junctional proteins was already observed
after two days of estradiol treatment, the majority of
b-catenin remained associated with E-cadherin. However,
the small fraction of E-cadherin–independent b-catenin in
the cytoplasm found after two days of estrogen treatment
was clearly increased after four-day treatment, and was
consistent with the diffuse cytoplasmic staining of b-cate-
nin found in immunofluorescence images at this stage. As
we already found a slight increase in b-catenin/LEF-1
transcriptional activity after four-day estrogen treatment,
this cytoplasmic pool of b-catenin might be involved in
signaling. A large amount of E-cadherin–independent
b-catenin, however, was only found in the mesenchymal
cells, when E-cadherin was no longer expressed at signifi-
cant levels. As b-catenin/LEF-1 transcriptional activity
was clearly upregulated in the mesenchymal cells, it may
be concluded that E-cadherin downregulation is important
for the regulation of b-catenin signaling activity in FosER
cells. This hypothesis is further confirmed by our observa-
tion that a related cell line (JunER) expressing a condi-
tionally active JunER-fusion protein lost epithelial polar-
ity upon induction of JunER activity (Fialka et al., 1996),
but did not lose E-cadherin expression nor upregulate b-cat-
enin/LEF-1 transcriptional activity.
The notion that the expression level of E-cadherin in-
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supported by the expression of exogenous E-cadherin
in mesenchymal cells, which led to a clear reduction of
LEF-1–dependent luciferase activity. Although alternative
mechanisms cannot be ruled out completely, it is most
likely that ectopically expressed E-cadherin bound b-cate-
nin and caused a reduction in the free pool of monomeric
b-catenin available for signaling. These results are in ac-
cordance with previous studies, showing a negative effect
of E-cadherin expression on the signaling activity of
b-catenin during early developmental stages of Xenopus
laevis (Heasman et al., 1994; Fagotto et al., 1996). Further-
more, it has recently been shown that transient expression
of full-length E-cadherin or of its cytoplasmic, b-catenin–
binding domain into various mammalian cell lines induced
the formation of complexes of b-catenin with ectopic pro-
teins at the plasma membrane or in the nucleus and inhib-
ited b-catenin/LEF-1–mediated transactivation (Sadot et al.,
1998; Orsulic et al., 1999). In our studies, the observed
z30–50% downregulation of b-catenin/LEF-1 transactiva-
tion activity upon transient E-cadherin expression in mes-
enchymal FosER cells was slightly less than the 50–70%
decrease reported upon expression of E- or N-cadherin in
E-cadherin–negative embryonic stem cells or in SW480
cells (Sadot et al., 1998; Orsulic et al., 1999). This differ-
ence could be explained by different expression levels of
ectopic E-cadherin in these cell systems.
It is still unclear how the expression of endogenous
E-cadherin is regulated during EMT. In vivo footprinting
analyses revealed that positive regulatory elements of the
E-cadherin promoter were specifically occupied by tran-
scription factors in polarized, but not in mesenchymal,
FosER cells (Hennig et al., 1995). Moreover, a LEF-1/
TCF recognition site has been identified upstream of these
elements, which was shown to bind to a b-catenin/LEF-1
complex in vitro (Huber et al., 1996b). It remains to be de-
termined whether b-catenin/LEF-1 complexes recognize
this site also in vivo and whether they influence the ex-
pression of E-cadherin in a positive or negative fashion.
Furthermore, b-catenin protein levels may also indirectly
influence the expression level of E-cadherin by stabilizing
E-cadherin in junctional complexes.
b-Catenin Signaling Is Upregulated in Mesenchymal 
FosER Cells 
Considering the criteria currently applied to identify b-cat-
enin as a signaling component in a given cellular system,
our data clearly indicated that b-catenin fulfills signaling
functions upon FosER-induced EMT. We found that
E-cadherin–independent b-catenin in mesenchymal FosER
cells was not associated with APC. As APC and axin have
been shown previously to downregulate b-catenin in colon
carcinoma cells (Rubinfeld et al., 1997; Behrens et al., 1998;
Hart et al., 1998), the lack of an APC/b-catenin complex in
FosER cells might cause the stabilization of cytoplasmic
b-catenin and make it available for its function in tran-
scriptional activation. In line with this, previous reports
implicated only uncomplexed monomeric b-catenin in sig-
naling functions, while b-catenin linked to various cyto-
plasmic complexes did not participate in signaling (Pap-
koff et al., 1996; Stewart and Nelson, 1997). In addition,
our pulse–chase experiments indicated that the stability of
b-catenin in mesenchymal cells is higher than that re-
ported in other E-cadherin–deficient cells and was close to
that of apparently transcriptionally active b-catenin in
melanoma cells or in wnt-induced cells (Papkoff et al.,
1996; Rubinfeld et al., 1997).
b-Catenin was also detected in the nucleus of mesenchy-
mal FosER cells. Many previous studies showed a strong
and more or less diffuse nuclear staining of b-catenin upon
gross overexpression of b-catenin and/or LEF-1 in mam-
malian cells (Behrens et al., 1996; Huber et al., 1996b). In
contrast, our studies identified endogenous b-catenin in
small spot-like structures within the nucleus. As many of
these structures were also stained by an affinity-purified
anti–LEF-1 antibody, they likely represent functional
b-catenin/LEF-1 complexes. Interestingly, ectopic expres-
sion of b-catenin in MDCK cells also revealed a concen-
tration of both b-catenin and LEF-1 in distinct nuclear
structures, rather than a diffuse nuclear staining of these
proteins (Simcha et al., 1998).
The notion that transcriptionally active b-catenin/LEF-1
complexes were formed in estradiol-treated FosER cells
was supported by our observation that LEF-1/TCF–depen-
dent luciferase reporter activity was clearly elevated in the
mesenchymal cells. The level of transcriptional b-catenin/
LEF-1 activation after FosER-induced EMT was clearly in
the range of that reported in previous studies upon expres-
sion of b-catenin and/or LEF-1 and/or wnt in various cell
systems (Korinek et al., 1997; Porfiri et al., 1997; Hsu et al.,
1998), or upon activation of integrin-linked kinase (Novak
et al., 1998), and can, therefore, be considered as signifi-
cantly high to be of functional relevance. Furthermore, in
earlier observations, relatively small differences in free
b-catenin on the dorsal versus ventral side of the Xenopus
embryo resulted in dorsal mesoderm formation (Larabell
et al., 1997), indicating that even subtle changes in the
level of signaling competent b-catenin may have a drastic
impact on gene activation.
Potential Molecular Mechanisms Leading to the 
Formation of Active b-Catenin/LEF-TCF Complexes in 
FosER Cells 
The molecular mechanisms underlying the formation of
an active b-catenin/LEF-TCF complex in mesenchymal
FosER cells remain unclear. Activation of the FosER fu-
sion protein might trigger specific signaling pathways that
regulate the interaction of b-catenin with the transcription
factors. Potential candidates for these additional signals
have been reported in various cell systems. In NIH3T3
cells, ectopically expressed wnt/wingless, a regulator of
GSK3b activity during embryonic development, was de-
scribed to induce the formation of a transcriptionally ac-
tive LEF-1/b-catenin complex in cells overexpressing
LEF-1, whereas LEF-1 expression alone was not sufficient
(Hsu et al., 1998). Similarly, wnt-1 expression in PC12 and
293 cells (Porfiri et al., 1997), and in a mammary epithelial
cell line (Korinek et al., 1998; Papkoff and Aikawa, 1998)
has been shown to induce the formation of active LEF-1/
b-catenin and TCF4/b-catenin complexes, respectively.
Furthermore, overexpression of integrin-linked kinase
(ILK) in mammary epithelial cells caused translocation of
b-catenin into the nucleus and induction of LEF/TCFThe Journal of Cell Biology, Volume 148, 2000 186
transcriptional activity (Novak et al., 1998). Thus, activa-
tion of FosER and integrin linked kinase might trigger sig-
naling pathways that are linked to the wnt-pathway or reg-
ulate the formation of an active nuclear b-catenin/LEF-1
complex via as yet unknown mechanisms.
In summary, our data showed that upon FosER-induced
EMT of mammary epithelial cells, b-catenin/LEF-1 tran-
scriptional activity is activated. Future studies involving
forced expression of E-cadherin in these cells at various
stages of EMT and the identification of b-catenin/LEF-1
target genes will help to identify the contributions of
b-catenin signaling to EMT and to unravel the specific
functions of b-catenin.
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